Impact of false-positive newborn metabolic screening results on early health care utilization

Ellen A Lipstein1, James M Perrin, Susan E Waisbren

  • 1Center for Child and Adolescent Health Policy, MassGeneral Hospital for Children, Boston, Massachusetts 02114, USA. elipstein@partners.org

Insights

False-positive newborn screening results did not significantly impact early healthcare use in children. This finding suggests that associated medical costs are primarily limited to diagnostic testing and follow-up care.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Newborn screening programs identify infants at risk for serious genetic, metabolic, and endocrine disorders.
  • False-positive results, while uncommon, can cause parental anxiety and may lead to increased healthcare utilization.

Purpose of the Study:

  • To investigate the association between false-positive newborn screening results and healthcare utilization in early childhood.
  • To determine if false-positive screening outcomes influence primary care visits, emergency room use, or hospitalizations.

Main Methods:

  • A survey was administered to parents of children with false-positive and normal newborn screening results.
  • Participants were recruited from Pennsylvania (false-positive) and Massachusetts (normal) birth registries.
  • Bivariate and multivariate regression analyses were employed to assess healthcare utilization by six months of age, controlling for covariates.

Main Results:

  • The study included 200 children with false-positive results and 137 with normal results.
  • Children with false-positive results were more likely to be non-white, have unmarried parents, and be of lower socioeconomic status due to recruitment variations.
  • After adjusting for covariates, no significant associations were found between newborn screening results and healthcare utilization.

Conclusions:

  • False-positive newborn screening results did not demonstrate a significant impact on early healthcare utilization.
  • These findings suggest that the primary medical costs associated with false-positive results are confined to diagnostic testing and follow-up procedures.
  • The study contributes to the economic evaluation of newborn screening programs by clarifying the impact on healthcare resource use.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Documentation of Nursing Diagnosis01:10

Documentation of Nursing Diagnosis

The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...